Back to results
US 10,293,035 B2Granted
Breast and ovarian cancer vaccines
AssigneeUniversity of Washington through its Center for Commercialization
InventorsMary L. Disis, Denise Cecil, Meredith Slota
Life of this patent
Estimating the term…
Abstract
The compositions described herein include an epitope of a peptide that may elicit an immune response in a subject following administration. The compositions may comprise nucleic acids. The compositions may comprise peptides. The methods described herein include administering a composition comprising an epitope of a peptide to a subject in need thereof.
Claims12
A composition comprising an amino acid sequence having at least 95% sequence identity to the amino acid sequence of SEQ ID NO:
- 39 or a fragment thereof, wherein SEQ ID NO:
- 39 or the fragment thereof is a fusion protein, and wherein SEQ ID NO:
- 39 or the fragment thereof comprise a plurality of epitopes, wherein the plurality of epitopes comprises all the amino acid sequences of SEQ ID NO:
- 1, SEQ ID NO:
- 16, SEQ ID NO:
- 20, SEQ ID NO:
- 25, and SEQ ID NO:
- 32.
5 more elements
Dependencies are inferred from the claim text.